Pulmonary hypertension due to lung diseases and hypoxia
ICD-10 I27.23 is a billable code used to indicate a diagnosis of pulmonary hypertension due to lung diseases and hypoxia.
Pulmonary hypertension due to lung diseases and hypoxia is a condition characterized by elevated blood pressure in the pulmonary arteries, which can arise from various lung diseases such as chronic obstructive pulmonary disease (COPD), interstitial lung disease, and sleep apnea. The pathophysiology involves vascular remodeling and increased resistance in the pulmonary circulation, leading to right ventricular strain and potential heart failure. Clinically, patients may present with symptoms such as dyspnea, fatigue, chest pain, and syncope. The anatomy involved includes the pulmonary arteries, right ventricle, and the lung parenchyma. Disease progression can be insidious, often leading to severe complications if not diagnosed and managed appropriately. Diagnostic considerations include echocardiography, right heart catheterization, and pulmonary function tests to assess the underlying lung disease and the severity of pulmonary hypertension. Early identification and treatment are crucial to improve patient outcomes and quality of life.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I27.23 encompasses pulmonary hypertension secondary to chronic lung diseases such as COPD, pulmonary fibrosis, and conditions leading to hypoxia, including sleep apnea. It is essential to document the underlying lung disease to support the use of this code.
I27.23 should be used when pulmonary hypertension is specifically due to lung diseases and hypoxia, distinguishing it from other forms of pulmonary hypertension such as those caused by left heart disease or chronic thromboembolic disease.
Documentation must include a clear diagnosis of pulmonary hypertension, evidence of underlying lung disease, and any relevant tests such as echocardiograms or pulmonary function tests that confirm the diagnosis and severity.
